About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 2NCT02127996

GLP-1 Loading During Elective Percutaneous Coronary Intervention

Angina is caused by narrowings or blockages within coronary arteries. Coronary angioplasty and stenting is performed for people with angina to improve the blood supply to the heart by placing metal tu...

Lead sponsor: Papworth Hospital NHS Foundation Trust•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Papworth Hospital NHS Foundation Trust

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Undergoing elective PCI
•Age over 18
•Able to give informed consent

Exclusion Criteria

•Severe co-morbidity (expected life expectancy \< 6 months)
•Nicorandil, glibenclamide, sitagliptin, vildagliptin, saxagliptin, linagliptin, liraglutide, exenatide and insulin use
•Women of child bearing age
•Breast-feeding women
•Myocardial infarction within the previous 3 months
•Baseline elevation of Troponin I before PCI
•Chronic Renal Impairment (serum creatinine \> 160 μmol/l)

Related studies

Arrhythmia Detection After MI

NCT05073419 · Acute Myocardial Infarction

Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI

NCT06353594 · ST Elevation Myocardial Infarction

RECRUITINGPhase 2

A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction

NCT07306182 · Anterior Myocardial Infarction

TROPOnin FRAGMentation in Myocardial Injury Study

NCT04465591 · Acute Myocardial Infarction Type 1, Myocardial Injury

RECRUITINGPhase 2

Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

NCT07362446 · Myocardial Infarction, Reperfusion Injury, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 6, 2018Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment193

Start dateMar 2015

Last updatedJun 6, 2018

Condition

Angina Pectoris Myocardial Infarction Reperfusion Injury Coronary Heart Disease

Locations shown

Papworth Hospital

Cambridge, Cambridgeshire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 6, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions